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SUMMARY 
The initial phase of the human T cell leukemia virus-1 (HTLV-1) infection of 
salivary gland epithelial cells (SGECs) was examined. SGECs of patients with 
Sjögren’s syndrome (SS) and non-SS subjects were co-cultured with the 
HTLV-1-infected cell line HCT-5 or MOLT-4, then immunofluorescence (IF), 
scanning and transmission electron microscopy (SEM/TEM) were employed.  
The extracellular matrix and linker proteins galectin-3, agrin, and tetherin were 
expressed on the surfaces of both HCT-5 and MOLT-4 cells. HTLV-1 
Gag-positive spots were observed on adjacent SGECs after 1 h of co-culture with 
HCT-5. Both in subjects with and those without SS, agrin and tetherin were 
co-expressed with HTLV-1 Gag on SGECs after co-culture with HCT-5, 
although no polarization of HTLV-1 Gag and relevant molecules was observed. 
SEM showed HTLV-1 virions that were found on HCT-5 were observed in the 
interfaces between HCT-5 cells and SGECs. TEM imaging showed that HTLV-1 
virions were transmitted to SGECs at the interface with thin film-like structure, 
while HTLV-1 virions were released from the surface of HCT-5 cells. No 
endogenous retroviruses were observed. These results showed that the initial 
phase of HTLV-1 infection toward SGECs of SS was mediated not by viral 
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synapses, but by biofilm-like components. 
(196 words) 
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Human T-cell leukemia virus-1 (HTLV-1) is a retrovirus that is directly involved 
in the etiology of adult T-cell leukemia (ATL), HTLV-1-associated myelopathy 
(HAM), and uveitis (1, 2). Regarding the relationship between autoimmune 
disease and HTLV-1, we demonstrated that tumor necrosis factor-alpha (TNF-α) 
inhibitors showed diminished efficacy for patients with HTLV-1-seropositive 
rheumatoid arthritis (3). Sjögren's syndrome (SS) is an autoimmune disease 
characterized by sicca symptoms, and the presence of anti-Ro/SS-A and 
anti-La/SS-B antibodies (4, 5), has been reported to be associated with some 
viruses, including Epstein-Barr virus (6) and cytomegalovirus (7). However, SS 
has not been recognized as part of the group of HTLV-1-associated diseases. 
Epidemiologically, a relationship between HTLV-1 and SS has been 
reported. In Nagasaki, an endemic area of HTLV-1, a high prevalence of HTLV-1 
in SS patients (23%) was reported among blood donors (8, 9). In studies in 1997 
and 2015, we reported a high prevalence of SS in our patients with HAM 
irrespective of the classification criteria applied (10, 11). In another study, we 
sought direct evidence of HTLV-1 infection in SS, and found that the salivary 
gland epithelial cells (SGECs) of patients with SS were infected with HTLV-1 
(12). Co-culture of HTLV-1-infected cells and SGECs for 72–96 h revealed 
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positive expressions of the HTLV-1 Gag proteins including p19, p28 that is one 
of gag protein intermediates, and Gag (HTLV-1 Gag) and elevated expressions of 
cytokines and chemokines such as soluble intercellular adhesion molecule 1 
(ICAM-1), regulated on activation, normal T cell expressed and secreted 
(RANTES), and interferon γ-induced protein 10-kd (IP-10) in both the culture 
medium and SGECs. However, the initial phase of the HTLV-1 infection of 
SGECs remained unclear. 
With respect to the HTLV-1 infection of CD4+ T lymphocytes, there are 
two major theories. Regarding the cell-to-cell infection of HTLV-1, the concept 
of virological synapses (VSs) was posited in a study by Igakura et al. (13), in 
which HTLV-1 viral proteins and genomes were reported to accumulate at the 
interface between HTLV-1-infected cells and target lymphocytes, accompanied 
by the polarization of ICAM-1 and lymphocyte function-associated antigen 
(LFA-1). The other theory involves the biofilm-like aggregation of extracellular 
matrix and cellular linker proteins, with the concept that aggregation of these 
proteins assist in the viral transmission (14). We conducted the present study to 
determine whether or not VSs or biofilm-like structures are directly associated 
with the transmission of HTLV-1 virions to SGECs obtained from patients with 
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SS as well as to SGECs from non-SS subjects. 
 
MATERIAL AND METHODS 
Patients with Sjögren's syndrome 
SGECs from labial salivary glands (LSGs) were obtained from twelve patients 
with suspected SS (all female; age: 58.8 ± 11.5 years). The classification of SS 
was performed based on the revised criteria proposed by the American-European 
Consensus Group (AECG) (15). All eight patients (age: 58.6±11.4 years) with 
pSS based on the AECG criteria were HTLV-1-seronegative as determined by a 
chemiluminescent enzyme immunoassay (CLEIA). Four non-SS subjects were 
defined as cases that did not fulfill the above classification criteria although they 
had xerostomia or xerophthalmia. 
 
Antibodies and reagents 
Rabbit anti-agrin antibody and goat anti-BST-2 (also known as tetherin) antibody 
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse 
anti-HTLV-1 (p19, p28, and Gag) antibodies were purchased from Chemicon 
International (Temecula, CA). Rabbit anti-galaectin-3 antibody, anti-talin 
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antibody, rabbit anti-alpha tubulin antibody, and mouse ICAM-1 antibody were 
purchased from Proteintech (Rosemont, IL). Rabbit anti-LFA-1 (also known as 
ITGB2) antibody was purchased from Lifespan BioSciences (Seattle, WA). 
Secondary antibodies including donkey anti-mouse IgG conjugated with 
fluorescein isothiocyanate (FITC) and donkey anti-rabbit IgG conjugated with 
tetramethyl rhodamine isothiocyanate (TRITC) were purchased from Jackson 
ImmunoResearch Laboratories (West Grove, PA). Hoechst dye 33258 was 
purchased from Sigma (St. Louis, MO). Mouse anti-tetherin (CD317, PDCA-1) 
neutralizing antibody was purchased from Thermo Fisher Scientific (Waltham, 
MA). Monoclonal rabbit anti-human cytokeratin 8/18 antibody mouse IgG1, 
normal rabbit serum and normal goat serum were purchased from Dako 
Cytomation (Glostrup, Denmark). 
 
Salivary gland biopsy and cell culture of epithelial cells 
A biopsy for the LSGs of the enrolled subjects was performed at the lower lip 
under local anesthesia. Some LSG samples were sent for the pathological 
diagnosis of sialadenitis. As reported previously (12), the remaining samples 
were used for the culture of SGECs in a defined keratinocyte–serum-free 
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medium (SFM) culture medium (Invitrogen Life Technologies, Carlsbad, CA) 
supplemented with hydrocortisone (Sigma) and bovine pituitary extract (Kurabo, 
Osaka, Japan). 
For the 1-hr co-cultures with SGECs in the defined keratinocyte-SFM 
culture medium, we used the HTLV-1-infected T-cell line HCT-5 (16, 17), which 
is derived from cerebrospinal fluid cells of a patient with HAM, and the 
non-HTLV-1 infected T-cell line MOLT-4. HCT-5 cells were subcultured in 20% 
fetal bovine serum (FBS) in RPMI 1640 medium supplemented with interleukin 
(IL)-2. MOLT-4 cells were maintained in RPMI 1640 medium with 10% FBS. 
Before the co-culturing, HCT-5 and MOLT-4 cells were cultured in 100-mm 
dishes. Our use of human samples following informed consent from the subjects 
was conducted with the approval of the Ethics Committee of Nagasaki University 
Hospital (approval no. 09102822-4). 
 
Immunofluorescence 
An immunofluorescence was performed as described previously (18). Briefly, 
SGECs were cultured on type I collagen-coated cover slips. After the co-culture 
with 1 × 106 cells of the HCT-5 or MOLT-4 cells, SGECs were washed with 
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phosphate-buffered saline (PBS) three times and fixed in phosphate-buffered 
saline (PBS) containing 4% paraformaldehyde and immersed in methanol. After 
blocking in 5% normal horse serum in PBS, the SGECs were incubated with the 
primary antibodies for 1 h at room temperature. Mouse IgG1, normal rabbit 
serum, and normal goat serum were used as isotype-matched controls. 
The cells were then incubated with FITC-conjugated and 
TRITC-conjugated secondary antibodies under dark conditions. The images were 
scanned using a fluorescence microscope (BZ-X710; Keyence, Osaka, Japan). 
The immunostaining of HCT-5 and MOLT-4 cells was performed in the same 
manner as described above for SGECs. For the optical microscopy observation of 
HCT-5 and MOLT-4 cells, an Olympus CK40 microscope was used. For 
improvement of images captured by BZ-X710, we analyzed by using haze 
reduction function that was introduced in previous reports (19, 20). 
 
Scanning electron microscopy (SEM) 
For the scanning electron microscopy examination, 1 × 106 HCT-5 or MOLT-4 
cells co-cultured with SGECs that were seeded on cover slips were washed with 
0.1 M phosphate buffer at room temperature five times for 10 min each time and 
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fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer. After being washed with 
0.1 M phosphate buffer four times, the samples were post-fixed for 2 h in 1% 
osmium tetroxide in 0.1 M phosphate buffer, then washed twice with 0.1 M 
phosphate buffer and dehydrated through a series of 50%, 70% and 80% ethanol 
solutions for 10 min at 4°C, followed by 90%, 95% and 99.5% ethanol solutions 
at room temperature. After substitution displacement with t-butyl alcohol at 40°C 
for 20 min each time, the samples were dried with vacuum freeze-drying 
equipment. Platinum film was used to cover the dried samples by sputter-coating 
(JFC-1600JEOL). The samples were mounted on a specimen support stage with 
carbon tape. A secondary electron image (SEI) or a lower secondary electron 
image (LEI) was captured by a JEOL JSM-6700F microscope with an emission 
gun operating at 8 kV. Regarding immune electron microscopy for SEM, HCT-5 
pellet was fixed in 4% paraformaldehyde (PFA) and dropped on carbon coating 
slides. After blocking with 1% bovine serum albumin in PBS, samples were 
incubated with or without mouse anti-HTLV-1 Gag antibody followed by 
incubation with anti-mouse secondary antibody conjugated with 10nm gold 
particle.  
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Transmission electron microscopy (TEM) 
First, 1 × 106 HCT-5 cells co-cultured with SGECs that were seeded on a 
collagen-coated chamber slide (Matsunami, Osaka, Japan) were washed with 0.1 
M phosphate buffer at room temperature five times and fixed hermitically in 
2.5% glutaraldehyde in 0.1 M phosphate buffer at 4°C for 4 h. After being 
washed with 0.1 M phosphate buffer four times, the samples were post-fixed for 
2 h in 1% osmium tetroxide in 0.1 M phosphate buffer and then washed twice 
with 0.1 M phosphate buffer and dehydrated through a series of 50%, 70% 
ethanol solutions for 10 min at 4°C, followed by 80%, 90%, 95%, 99.5% and 
100% ethanol solutions at room temperature. We created an epoxide resin that 
consisted of a base compound, curative agent and accelerating agent, and then 
filled a beam capsule with the epoxide resin. The beam capsule was inverted on 
the chamber slides, and the samples were thermal polymerized at 50°C for 72 h. 
Each detached specimen with polymerized epoxy resin was sliced thinly using an 
ultramicrotome (ULTRACUT Leica, Wetzlar, Germany). Counterstaining of the 
sections was performed by using uranyl acetate and lead nitrate. Images were 
captured by a JEOL JEM-1200EX microscope for the TEM examination. 
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Regarding immune electron microscopy for TEM, HCT-5 pellet was fixed in 4% 
paraformaldehyde (PFA) and dehydrated. Then, heat polymerization was 





Co-expression of extracellular matrix and linker proteins on SGECs after 
co-culture 
Extracellular matrix proteins including galectin-3, agrin and tetherin were 
expressed on the surface of HCT-5 cells (Fig. 1A). These three molecules were 
co-expressed with HTLV-1 Gag, although the co-expression was limited to a 
small area. Although MOLT-4 cells also expressed galectin-3, agrin, and tetherin 
(Fig. 1B), the expression of these molecules was weaker compared to that on 
HCT-5 cells. No expression of HTLV-1 Gag on MOLT-4 cells was observed. The 
HCT-5 cells showed some emitted dots around the cells (Fig. 2A). After the 1-hr 
co-culture of SGECs and HCT-5 cells, dot signals of HTLV-1 Gag were observed 
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on the surface of cytokeratin 8/18-positive SGECs adjacent to HCT-5 cells (Fig. 
2B), although these Gag signals were not observed in the nuclei of the SGECs. 
In contrast, the SGECs co-cultured with MOLT-4 cells showed no dotted 
staining of HTLV-1 Gag proteins (Fig. 2C). In addition, only the MOLT-4 cells 
lacked HTLV-1 Gag protein expression (Fig. 2C). Without co-culturing, no 
expression of Gag protein was observed on SGECs (Suppl. Fig. S1A). After the 
1-hr co-culture of SGECs with HCT-5 cells, no co-expression of galectin-3 and 
HTLV-1 Gag signal was observed on SGECs, although galectin-3 was expressed 
on SGECs (Fig. 3A). 
In contrast, agrin and tetherin were co-expressed with HTLV-1 Gag, and 
tetherin in particular showed a high frequency of co-expression compared to the 
co-expressing area with agrin (Fig. 3A). The co-expression of Gag protein and 
galectin-3, agrin, and tetherin on SGECs in other cases is shown in 
Supplementary Figure S1B, in which the co-expression of Gag protein with 
agrin and tetherin was observed as mentioned above. The expressions of 
galectin-3, agrin, and tetherin on SGECs before co-culturing with HCT-5 cells 
were not significantly different from those after the co-culture (Suppl. Fig. S1A). 
When SGECs were co-cultured with MOLT-4 cells, no HTLV-1 Gag signal was 
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observed, although galectin-3 and agrin were expressed on the MOLT-4 cells 
(Fig. 3B). These findings were similar whether the SGECs were derived from 
patients with pSS or non-SS subjects. To confirm importance of biofilm-like 
structure, we showed inhibition test toward tetherin. By using 2μg/ml and 
20μg/ml neutralizing antibody toward tetherin, no obvious reduced expression of 
tetherin on both HCT-5 and SGECs was observed after co-culture with HCT-5 
and SGECs at 1 and 24 h (Suppl. Fig. S2).  
 
 
No virological synapse formation in the co-cultures of SGECs with HCT-5 
cells 
After the 1-hr co-culture of SGECs with HCT-5, no polarization of HTLV-1 Gag 
proteins was observed at the contact surface of these cells (Fig. 4A). In addition, 
no accumulation of talin (one of the structural components of VSs) was observed 
at the interface. No polarization of another component, α-tubulin, was observed 
after co-culture with HCT-5 cells (Fig. 4A). The expression of ICAM-1 was 
observed on the surface of HCT-5 cells, but there was no polarization of ICAM-1 
on HCT-5 cells and LFA-1 on SGECs at the interface. The SGECs co-cultured 
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with MOLT-4 cells showed no polarization of talin and LFA-1 without the 
expression of HTLV-1 Gag and ICAM-1 signals (Fig. 4B). These findings were 
similar whether the SGECs were derived from patients with pSS or non-SS 
subjects. 
We observed the expression of VS-related proteins as well as extracellular matrix 
and linker proteins before the co-culturing (Suppl. Fig. S1). 
 
Detection of HTLV-I virions on the surface of co-cultured SGECs 
Although HCT-5 cells have a more cilia-like structure on the surface (Fig. 5A) 
under an optical microscope compared to MOLT-4 cells (Fig. 5B), the SEM 
images showed a complicated surface (Fig. 5C) with many particles of 
approximately 100-nm diameter with different sizes (Fig. 5D). Immune electron 
microscopy for HCT-5 pellet showed that compared to control staining without 
primary antibody (Fig. 5E) some gold particles were detected in backscattered 
electron image (BEI) by incubation with anti- HTLV-1 Gag antibody followed by 
10nm gold particle conjugated secondary antibody  (Fig. 5F). HCT-5 cells with 
a number of foot processes contacted SGECs (Fig. 5EG,FH). SEM images also 
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showed that small particles (approximately 100 nm in diameter) were present in 
the area between HCT-5 cells and SGECs (Fig. 5GI,HJ). 
TEM images revealed HTLV-1 virions with an envelope on the surface of 
HCT-5 cells (Fig. 6A). Differences in the sizes of the virions were observed, and 
the budding of hemispherical virions was seen on the surface membrane of 
HCT-5 cells, showing one of the characteristics of a type C retrovirus (Fig. 6B). 
Immune electron microscopy for HCT-5 pellet showed that compared to control 
staining without primary antibody (Fig. 6C) many gold particles were detected 
by incubation with mouse anti-HTLV-1 Gag antibody followed by 10nm gold 
particle conjugated secondary antibody (Fig. 6D). The TEM imaging showed 
foot processes on the surface at the junction of HCT-5 cells and SGECs (Fig. 
6CE), and the release of HTLV-1 virions occurred among other cellular 
components (Fig. 6DF). At high magnification, virions of approximately 100-nm 
diameter were detected on the HCT-5 side (Fig. 6EG). Similarly, virions were 
also detected at the SGEC side (Fig. 6FH). In addition, a thin film-like structure 
was observed on the surface of HCT-5 cells (Fig. 6A right panel, 6DF) and 
SGECs (Fig. 6FH). 
We also confirmed that there were no released virions at the interface between 
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MOLT-4 cells and SGECs by SEM and TEM in a control experiment (Suppl. Fig. 
S3). Although typical SGECs had microvilli on their surface (Suppl. Fig. S3B,F), 
the MOLT-4 cells had an irregular surface and remarkable notch on the nucleus 
(Suppl. Fig. S3A,E) and made smooth contacts with the SGECs (Suppl. Fig. 
S3C,D,G,H). We also confirmed that there were no endogenous retroviruses on 
the surface of the SGECs (Suppl. Fig. S3B). 
 
DISCUSSION 
Our findings revealed that, unlike VSs, the biofilm-like structure of extracellular 
and linker proteins facilitated the transmission of HTLV-1 virions to SGECs. 
With respect to definition of initial phase regarding contact between 
HTLV-1-infected cell line and non-immune SGECs, there was no clear standard. 
Therefore, we drew upon the descriptions by Pais-Correia (14), in which 
important molecules or time course were demonstrated for experiments between 
HTLV-1-infected and uninfected lymphocytes. With respect to autoimmune 
diseases, including SS and rheumatoid arthritis, some reports have described a 
relationship between HTLV-1 infection and these disorders (21, 22). With regard 
to the direct infection of non-lymphocytes by HTLV-1, some in vitro studies have 
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used retinal glial cells or synovial cells (23, 24), but their analyses were of 3–
7-day co-cultures with an HTLV-1-infected cell line. In our study of SGECs 
co-cultured with HCT-5 cells, the cytoplasmic expression of HTLV-1 Gag 
proteins was observed at ≥72 h (12). The expression of HTLV-1 Gag proteins in 
these studies was thought to occur in response to the integration of HTLV-1 into 
the host cell genome. Our findings demonstrating that galectin-3 showed no 
co-expression with HTLV-1 Gag appear to differ from the previous reported on 
HTLV-1-infected lymphocytes, in which galectin-3 and HTLV-1 Gag were 
co-expressed on the surface of HTLV-1-infected lymphocytes (14). However, our 
findings suggest the possibility that at least two molecules are involved in the 
assembly of extracellular matrix proteins with HTLV-1 virions. Although 
neutralizing test with anti-tetherin antibody showed no obvious effect, functional 
activity of tetherin was not determined. Regarding viral biofilms involved in 
HTLV-1 infection, Tarasevich et al. (25) reported the up-regulation of CD4, 
CD150, CD25, and CD80 in biofilms in response to HTLV-1 infection. 
Regarding the expression of the tax gene in HCT-5 cells, we observed a 
detectable basal-level expression of both tax as well as HTLV-1 bZIP factor 
(HBZ), and proviral load before the addition of TNF inhibitors (26), indicating 
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that tax might be associated with the expression of cytokines in the HCT-5 cell 
line. 
Although HTLV-1 was mainly transmitted between HTLV-1-infected cells 
and uninfected lymphocytes, other types of cells should be examined in this 
context, including dendritic cells (DCs) and other epithelial cells. The 
involvement of DCs should be considered because cell-free HTLV-1 virions have 
been shown to have the potential to infect DCs (27). Since a cell-free HTLV-1 
infection of plasmatoid DCs (pDCs) was reported to transfer HTLV-1 virions to 
CD4+ T cells (28), the role of pDCs in SS might be crucial for the effective in 
vivo transmission of HTLV-1 virions between HTLV-1-infected and 
HTLV-1-uninfected cell types. Regarding cell-free HTLV-1 infection and 
transmission toward DCs, the involvement of a DC-specific intracellular 
adhesion molecule-3-grabbing nonintegrin (DC-SIGN) was reported (29), 
suggesting that a DC-mediated viral transmission system might be involved in 
cases of HTLV-1 infection of salivary gland epithelial cells. Recent study with 
respect to relationship between innate immunity and HTLV-1 infection also 
showed importance of HTLV-1-related glycan-rich viral structure that is 
mediated by antiviral response detected in pDCs (30). From a view point of 
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relationship between saliva and HTLV-1 infection, simian T-leukemia virus type 
1 (STLV-1) and simian foamy virus (SFV) in saliva of primates except humans 
are shown (31). Because STLV-1 and SFV in saliva of primates was reported to 
transmit to blood of recipients as humans, role of saliva might have a crucial role 
for transmission of retroviruses. 
With regard to VSs, it was reported (13) that the polarization of a microtubule 
organizing center (MTOC) (32, 33) and the accumulation of talin (one of the 
cytoskeletal proteins) played crucial roles in the delivery of HTLV-1 virions from 
HTLV-1-infected cells to uninfected cells. Human immunodeficiency virus type 
-1 (HIV-1) also uses VSs with the polarization of virus proteins (34), and two 
components, the Gag capsid protein and envelope glycoproteins, were shown to 
assist in the turnover of HIV-1 VSs. It was also reported that in a VS model in 
HIV-1, LFA-1 had the potential to polarize VS and recruit an MTOC (35). From 
the expression of LFA-1on SGECs, we should take cellular conduits into 
consideration. It was reported (36) that HTLV-1-encoded p8 protein assisted 
HTLV-1 transmission toward uninfected T lymphocytes. They showed HTLV-1 
was transmitted by cellular conduits that were filopodium-like protrusion with p8 
that was cleaved from precursor p12. Because foot processes were observed on 
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the surface of HCT-5 at the interface, the presence of cellular conduits should be 
considered. Because they demonstrated clustering of LFA-1 was required for 
cellular conduits formation, the findings were different from our observations 
that indicated no accumulation of LFA-1 at the interface in 1h co-culture. 
However, we should carefully consider the possibility for the presence of cellular 
conduits because they observed clustering of LFA-1 at 20 minutes co-culture. We 
observed no cellular conduits formation at 0 and 3 minutes, but short cellular 
conduits appeared at 20 minutes without accumulation of LFA-1 (Suppl. Fig. 
S4). Finally, we found longer cellular conduits formation toward adjacent SGEC 
at 60 minutes. Although the defective accumulation of LFA-1 or time points was 
different from the previous report (36), similar condition might exist between 
HCT-5 and SGECs. 
With respect to the HTLV-1 infection of epithelial cells, a previous report 
demonstrated the HTLV-1 infection of enterocytes with microvilli using TEM 
(37), and also showed that free virions were present at the interface between 
HTLV-1-infected cells and epithelial cells. In follicular epithelial cells from 
HTLV-1-positive individuals with Hashimito’s thyroiditis, no HTLV-1 particles 
were detected by electron microscopy despite the detection of HTLV-1 viral 
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proteins and mRNA (38). That finding differs from the results of our previous 
study (39), which demonstrated the expression of HBZ in salivary epithelial cells 
by in situ hybridization. Therefore, it might be difficult to detect 
HTLV-1-associated molecules or virions in different epithelial cell types or under 
different specimen-processing conditions. 
With regard to the detection of retrovirus by TEM, Yamano et al. (40) 
reported that they observed A-type-like retroviral particles in SGECs of SS 
patients with positive reverse transcriptase activity. However, the current 
understanding is that HTLV-1 infection is not confirmed unless the SS patient is 
positive for anti-HTLV-1 antibody. We have also considered the possibility of 
human endogenous retroviruses (HERVs) because HERVs were detected in a 
teratocarcinoma cell line (41, 42). Since we detected no virus-like particles on the 
SGECs that were co-cultured with MOLT-4 cells despite extensive observations, 
we confirmed that the type C virions on SGECs that were co-cultured with 
HCT-5 cells were not HERVs. 
This study has some limitations. The routes over which HTLV-1 virions 
travelled from the surface of SGECs to the nucleus were not elucidated.  
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In addition, due to technical problems during the preparation process, we did not 
label HTLV-1 proteins toward samples with SGECs with immunogold particles 
for the electron microscopy. However, we could confirm that the particles on 
HCT-5 only samples were HTLV-1 by using anti-mouse secondary antibody 
conjugated with gold particles. With regard to neutralizing test, affinity of 
neutralizing antibodies toward tetherin antigen might be associated with negative 
results in Suppl. Fig S2. In a future study, we plan to investigate the possibility of 
the interaction of other immune cells such as or macrophages in vivo or the 
aforementioned dendritic cells. 
Taken together, our present findings provide the first description of the 
initial dynamic state of HTLV-1 virions at the interface between HCT-5 cells and 
SGECs. We elucidated that part of the biofilm-like assemblies of the extracellular 
matrix and linker proteins played a crucial role in transmitting the HTLV-1 
released by HTLV-1-infected cells to the SGECs. 
(Word count: 36592978) 
 
Key messages 
The HTLV-1-infected cells have the extracellular matrix and linker proteins on 
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their surface. 
 
Biofilm-like components including agrin and tetherin were involved in 
transmission of HTLV-1 toward SGECs. 
 
An electron microscopy confirmed transmission of virions at the interface 
between HCT-5 cells and SGECs. 
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Figure legends 
Fig. 1. Expression of biofilm component in HCT-5 cells. A: Expression of 
extracellular matrix and linker proteins on HCT-5 cells. After fixation, the 
SGECs were reacted with primary antibodies including mouse anti-HTLV-1 Gag 
antibody (mGag), rabbit anti-galectin-3 (rgalectin-3), agrin antibodies (ragrin) 
and goat anti-tetherin antibody (gtetherin) followed by FITC-conjugated 
anti-mouse and TRITC-conjugated anti-rabbit or goat secondary antibodies. 
Arrowheads: Extracellular matrix and linker proteins, Gag and co-expression on 
the surface of HCT-5 cells. B: Expression of extracellular matrix and linker 
proteins on MOLT-4 cells. The same primary and secondary antibodies were 
used as for HCT-5 cells. Bright field images were simultaneously captured. 
Representative results of five independent experiments with similar findings are 
shown. Hoechst 33258 was used for counterstaining. mIgG1: mouse IgG1. NRS: 
normal rabbit serum. NGS: normal goat serum. Bar: 10 μm. 
 
Fig. 2. Detection of HTLV-1 Gag protein on the surface of SGECs. A: After 
the SGECs were co-cultured for 1 h with HCT-5 cells, the fixed cells were 
stained with mouse antibody against HTLV-1 Gag proteins (mGag) and rabbit 
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antibody against an SGEC marker, cytokeratin 8/18 (rcyto8/18). Arrowhead: 
Emitted HTLV-1 Gag particles from HCT-5. Insets: Magnified images of 
HTLV-1 Gag particles. B: Representative images of the interface between 
HCT-5 cells and SGECs. Arrowheads: HTLV-1 Gag particles transmitted toward 
SGECs. Insets: Magnified views of HTLV-1 particles emitted toward SGECs. C: 
Images of the co-culture of MOLT-4 cells and SGECs are shown as a control 
(upper panel). Only MOLT-4 cells were stained with mouse anti-HTLV-1 Gag 
antibody (lower panel). Bright field images were simultaneously captured. 
Representative results of five independent experiments with similar findings are 
shown. Hoechst 33258 was used for counterstaining. Bar: 10 μm. 
 
Fig. 3. Co-expression of extracellular matrix and linker proteins after 
co-culture. A: After the SGECs were co-cultured for 1 h with HCT-5 cells, the 
fixed cells were stained with mouse anti-HTLV-1 Gag antibody (mGag), rabbit 
anti-galectin-3 (rgalectin-3), agrin antibodies (ragrin) and goat anti-tetherin 
antibody (gtetherin) followed by FITC-conjugated anti-mouse and 
TRITC-conjugated anti-rabbit or goat secondary antibodies. Arrowhead: 
HTLV-1 Gag protein, matrix, and linker proteins or a merged view of these 
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proteins. B: SGECs were also co-cultured with MOLT-4 cells for 1 h. The same 
primary and secondary antibodies were used as for the HCT-5 cells. 
Representative results of five independent experiments with similar findings are 
shown. Hoechst 33258 was used for counterstaining. mIgG1: mouse IgG1. NRS: 
normal rabbit serum. NGS: normal goat serum. Bar: 10 μm. 
 
Fig. 4. Detection of virological synapse formation. A: After the SGECs were 
co-cultured for 1 h with HCT-5 cells, the fixed cells were stained with mouse 
anti-HTLV-1 Gag (mGag) or ICAM-1 antibody (mICAM-1), or with rabbit 
anti-cyto8/18 (rcyto8/18), Talin (rtalin), LFA-1 (rLFA-1) or alpha-tubulin 
(rtubulin) antibodies followed by FITC-conjugated anti-mouse and 
TRITC-conjugated anti-rabbit secondary antibodies. Arrowhead: The interface 
between HTLV-1 Gag protein or a merged view of the surface HCT-5 cells and 
SGECs. B: The same primary and secondary antibodies were used as described 
for panel A. Representative results of four independent experiments with similar 
findings are shown. Hoechst 33258 was used for counterstaining. Bar: 10 μm. 
 
Fig. 5. Detection of HTLV-1 virions by scanning electron microscopy. A: 
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HCT-5 cells and (B) MOLT-4 cells viewed by optical microscopy. Insets: 
Magnified view of respective cells. C: Typical view of an HCT-5 cell by SEM. 
D: Magnified view of the surface of an HCT-5 cell. Arrowheads: 100-nm 
particles. E, F: Immune electron microscopy images were shown. HCT-5 cell 
pellet fixed with 4% PFA was used for post embedding staining without mouse 
anti-HTLV-1 Gag antibody (E) or with anti-HTLV-1 Gag antibody (F) followed 
by 10nm gold particle conjugated anti-mouse secondary antibodies. Left panels 
and right panels showed SEI and backscatterd electron image (BEI) of same 
location, respectively. Arrowheads showed positive spots in BEI and outlined 
arrowheads showed corresponding points in SEI. EG,FH: Proximity between 
HCT-5 and SGECs. Secondary electron images (SEIs) are shown. Alternatively, 
a lower secondary electron image (LEI) was used when the SEI showed the 
charge-up phenomenon that expressed an unstable abnormal contrast by a 
deviated track of a secondary electron. GI,HJ: Detection of HTLV-1 virions at 
the interface between HCT-5 and SGECs by SEM. White squares show images 
taken under increasingly greater magnification. Arrowheads indicate the enlarged 
view of virions. Representative results of three independent experiments with 
similar findings are shown.  
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Fig. 6. Detection of HTLV-1 virions by transmission electron microscopy. A: 
The typical appearance of an HCT-5 cell with virions on the surface by 
transmission electron microscopy (TEM) is shown in the left panel. A magnified 
view of the surface of another HCT-5 cell is show in the right panel. The inset 
shows an enlarged view of the virions. B: Differences in size were observed in 
mature HTLV-1 virions with an envelope and rod-shaped nucleus on the foot 
processes of HCT-5. Left inset: An enlarged view of HTLV-1 virions. Right inset: 
Hemispherical virions (arrowheads) were budding from the surface of the HCT-5 
cells. C and D: Immune electron microscopy was shown. HCT-5 cell pellet fixed 
with 4% PFA was used for post embedding staining without mouse anti-HTLV-1 
Gag antibody (C) or with anti-HTLV-1 Gag antibody (D) followed by 10nm gold 
particle conjugated anti-mouse secondary antibody. CE: Contact between an 
HCT-5 cell and an SGEC is shown. DF: Detection of HTLV-1 virions at the 
interface between HCT-5 cells and SGECs. EG: Black arrowheads: HTLV-1 
virions of approximately 100-nm diameter on the surface of an HCT-5. FH: 
Virions on the SGECs side. The outlined arrowheads in A, DF and FH indicate 
the thin film-like structure. Representative results of three independent 
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experiments with similar findings are shown. 
 
Suppl. Fig. S1. Expression of biofilm and VS-related molecules before and 
after co-culture. A: The expression of HTLV-1 Gag was first examined without 
co-culture with HCT-5 or MOLT-4 cells. After fixation, the SGECs were reacted 
with mouse anti-HTLV-1 Gag antibody (mGag) or mouse IgG1 followed by 
FITC-conjugated anti-mouse secondary antibodies. The expression of biofilm 
and VS-related molecules including galectin-3, agrin and tetherin, LFA-1, talin 
and alpha-tubulin were then examined by reacting with primary antibodies 
including rabbit anti-galectin-3 (rgalectin-3), agrin (ragrin), LFA-1 (rLFA-1), 
Talin (rtalin) and alpha-tubulin (rtubulin) antibodies, goat anti-tetherin antibody 
(gtetherin), normal rabbit serum (NRS) or normal goat serum (NGS) followed by 
TRITC-conjugated anti-rabbit or goat secondary antibodies. Representative 
results of three independent experiments with similar findings are shown. B: 
HTLV-1 Gag protein and galectin-3, agrin, and tetherin co-expressed cases that 
are not shown in Figure 3. In the six cases, white arrowheads and outlined 
arrowheads indicate merged and unmerged cases, respectively. 
Hoechst 33258 was used for counterstaining. Bar: 10 μm. 
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Suppl. Fig. S2. Inhibition of tetherin on SGECs by neutralizing antibody.  
The SGECs were co-cultured for 1 and 24 h with HCT-5 cells in the presence or 
absence of indicated concentration of mouse anti-tetherin neutralizing antibody. 
The fixed cells were stained with mouse anti-HTLV-1 Gag (mGag: green) or 
with goat anti-tetherin antibody (gtetherin: red) followed by FITC-conjugated 
anti-mouse and TRITC-conjugated anti- goat secondary antibodies. Arrowheads 
showed co-expression of HTLV-1 Gag and tetherin. Representative results of 
two independent experiments with similar findings are shown. Hoechst 33258 
was used for counterstaining. Bar: 10 μm. 
 
 
Suppl. Fig. S3. Co-culture of SGECs with MOLT-4 cells, observed by EM.  
A–D: Magnified view between a MOLT-4 cell and an SGEC by SEM. The SEI 
image was taken after the specimen was sputtered with platinum. A: Typical 
view of a MOLT-4 cell. B: SGECs co-cultured with MOLT-4 cells. Inset: 
Enlarged view of the surface of an SGEC. C,D: Contact of MOLT-4 cell with an 
SGEC. Asterisks: Interface. E–H: Magnified view between a MOL-4 cell and 
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SGEC obtained by TEM after making thin-sliced sections from polymerized 
epoxy resin. E: TEM image of a MOLT-4 cell. F: SGECs co-cultured with 
MOLT-4 cells. G: Interface between a MOLT-4 cell and an SGEC. H: Enlarged 
view of panel G. Representative results of two independent experiments with 
similar findings are shown. 
 
Suppl. Fig. S4. Formation of cellular conduits between HCT-5 and SGECs.  
After the SGECs were co-cultured for 0, 3, 20 and 60 minutes with HCT-5 cells, 
the fixed cells were stained with mouse anti-HTLV-1 Gag (mGag) or with rabbit 
anti-cyto8/18 (rcyto8/18), LFA-1 (rLFA-1) antibodies followed by 
FITC-conjugated anti-mouse and TRITC-conjugated anti-rabbit secondary 
antibodies. Enlarged view of cellular conduits was shown in inset at 60 minutes. 
Bright field images were simultaneously captured. Representative results of three 
independent experiments with similar findings are shown. Hoechst 33258 was 
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